13th Process Development for Highly Potent Drugs Summit (HPAPI)

[email protected]

Philadelphia, Pennsylvania, United States


From Process Safety to Rapid Scale-Up to Tech Transfer: Integrating Process Development, Industrial Hygiene and Equipment Selection to Achieve GMP Manufacturing of Novel High Potent Drug Compounds 2023 has been a pivotal year for novel high potent compounds securing early success and approvals – from Henlius’s ADC to Gilead’s Trodelvy to BMS’s Augtyro, cementing the growth of highly potent drugs market to reach USD$40.7bn by 2023.

Time: 1:30 PM - 3:45 PM

Latest from Events